Skip to main content

Amino Acids Determining Specificity to OP-Agents and Facilitating the “Aging” Process in Human Acetylcholinesterase

  • Chapter
Enzymes of the Cholinesterase Family

Abstract

Cholinesterases (ChE’s) are readily phosphylated at the active site serine, by a variety of organophosphorus agents (OP) (Aldrich et al., 1972; Taylor, 1990). The enzyme can be reactivated by various oxime nucleophiles but in certain cases reactivation is thwarted due to a concomitant unimolecular process termed aging (Aldrich et al., 1972). The aged enzyme-OP-conjugate is refractive to reactivation (Gray, 1984) and thus renders treatment, following intoxication with certain OP insecticides or nerve gas agents, extremely difficult (Glickman et al., 1984). Recombinant human acetylcholinesterase (HuAChE) and several selected active site gorge mutants: W86A, E202Q, F295A, F297A, Y337A and E450A of HuAChE were studied with respect to catalytic activity towards charged and noncharged substrates, phosphylation by organophosphorus (OP) inhibitors: DFP, paraoxon and soman and subsequent aging of the resulting OP-conjugates. On the basis of these studies we have identified some of the critical elements in the active center that determine specificity to various OP-agents. Trp86, a key element of the active center “anionic subsite” that stabilizes noncovalent complexes of charged ligands by cation - π interactions (Ordentlich et al., 1993a) also contributes to chemical reactivity towards various noncharged OP - inhibitors as manifested by a 5–20 fold decrease in rates of phosphorylation observed for W86A mutant. Replacement of Tyr337 by alanine had a minimal effect on the bimolecular rate constant of inhibition by the OP-molecules. The 20-fold increase in phosphorylation rates of the F295A mutated enzyme by paraoxon is attributed to the better accommodation of the ethoxy moiety of the inhibitor by the less bulky alanine residue. This is consistent with the role of Phe295 in conferring specificity to the acyl pocket (Ordentlich et al., 1993a). The reduction in catalytic efficiency displayed by the E202Q and E450A mutants, and the marked decrease in the rates of both phosphylation and aging is consistent with the proposed role of these residues as key elements of the hydrogen bond network (Ordentlich et al., 1993b). The role of this network is to maintain the functional architecture of the active center and proper positioning of E202, thereby stabilizing the evolving transition states of acylation and phosphylation. The impaired “aging” process displayed by the E202Q and E450A mutants provides a basis for the engineering of novel reactivatable bioscavengers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aldrich, W.N., and Reiner, E. (1972). Enzyme Inhibitors as Substrates, North-Holland Publishing Co., Amsterdam.

    Google Scholar 

  • Glickman, A.H., Wing, K.D. and Casida, J.E. (1984). Toxicol. Appl. Pharmacol. 73, 16–22.

    Article  PubMed  CAS  Google Scholar 

  • Gray, A.P. (1984). Drug Metabolism Rev. 15, 557–589.

    Article  CAS  Google Scholar 

  • Ordentlich, A., Barak, D., Kroman, C., Flashner, Y., Leitner, M., Segall, Y., Ariel, N., Cohen, S., Velan, B. and Shafferman, A. (1993a). J. Biol. Chem. 268, 17083–17095.

    PubMed  CAS  Google Scholar 

  • Ordentlich, A., Kronman, C., Barak, D., Stein, D., Ariel, N., Marcus, D., Velan, B. and Shafferman, A. (1993b). FEBS Lett. 334, 215–220.

    Article  PubMed  CAS  Google Scholar 

  • Taylor, P. (1990), in: The Pharmacological Basis of Therapeutics, 8th Ed. (Gilman, A.G., Rall, T.W., Nies, A.S. and Taylor, P., Eds.), pp 131–149, Macmillan Publishing Co., New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ordentlich, A. et al. (1995). Amino Acids Determining Specificity to OP-Agents and Facilitating the “Aging” Process in Human Acetylcholinesterase. In: Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P. (eds) Enzymes of the Cholinesterase Family. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1051-6_43

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1051-6_43

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1053-0

  • Online ISBN: 978-1-4899-1051-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics